Literature DB >> 17205023

Immunomodulation by n-3- versus n-6-rich lipid emulsions in murine acute lung injury--role of platelet-activating factor receptor.

Martina Barbara Schaefer1, Juliane Ott, Andrea Mohr, Ming Hua Bi, Andrea Grosz, Norbert Weissmann, Satoshi Ishii, Friedrich Grimminger, Werner Seeger, Konstantin Mayer.   

Abstract

OBJECTIVE: Cytokines, platelet-activating factor (PAF), and eicosanoids control local and systemic inflammation. Conventional soybean oil-based lipid emulsions used for parenteral nutrition may aggravate the leukocyte inflammatory response or adhesion to the vessel wall. Fish oil-based lipid emulsions, in contrast, may exert an anti-inflammatory effect.
DESIGN: We investigated the impact of lipid emulsions on leukocyte invasion, protein leakage, and cytokines in two murine models of acute inflammation.
SETTING: Research laboratory of a university hospital.
SUBJECTS: Wild-type mice and PAF-receptor knockout mice.
INTERVENTIONS: Mice received an infusion of normal saline, fish oil- or soybean oil-based lipid emulsions before lipopolysaccharide challenge.
MEASUREMENTS AND MAIN RESULTS: Preinfusion with soybean oil resulted in increased leukocyte invasion, myeloperoxidase activity, and protein leakage and exaggerated release of tumor necrosis factor (TNF)-alpha as well as macrophage inflammatory protein (MIP)-2 into the alveolar space after intratracheal lipopolysaccharide challenge. In contrast, preinfusion with fish oil reduced leukocyte invasion, myeloperoxidase activity, protein leakage, and TNF-alpha as well as MIP-2 generation. Corresponding profiles were found in plasma following intraperitoneal lipopolysaccharide application: Soybean oil increased but fish oil decreased the TNF-alpha and MIP-2 formation. When PAF-receptor-deficient mice were challenged with lipopolysaccharide, leukocyte invasion, lung tissue myeloperoxidase, cytokine generation, and alveolar protein leakage corresponded to those observed in wild-type animals. Fish oil and soybean oil lost their diverging effects on leukocyte transmigration, myeloperoxidase activity, leakage response, and cytokine generation in these knockout mice. Similarly, the differential impact of both lipid emulsions on these lipopolysaccharide-provoked changes was suppressed after pretreating animals with a PAF-receptor antagonist.
CONCLUSIONS: Fish oil- vs. soybean oil-based lipid infusions exert anti- vs. proinflammatory effects in murine models of acute inflammation. The PAF/PAF-receptor-linked signaling appears to be a prerequisite for this differential profile.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17205023     DOI: 10.1097/01.CCM.0000253811.74112.B6

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  11 in total

Review 1.  Fish oil in critical illness: mechanisms and clinical applications.

Authors:  Renee D Stapleton; Julie M Martin; Konstantin Mayer
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

2.  Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids.

Authors:  Konstantin Mayer; Almuth Kiessling; Juliane Ott; Martina Barbara Schaefer; Matthias Hecker; Ingrid Henneke; Richard Schulz; Andreas Günther; Jingdong Wang; Lijun Wu; Joachim Roth; Werner Seeger; Jing X Kang
Journal:  Am J Respir Crit Care Med       Date:  2009-01-08       Impact factor: 21.405

3.  Modulation of endothelial cell integrity and inflammatory activation by commercial lipid emulsions.

Authors:  Kevin A Harvey; Zhidong Xu; Thomas M Pavlina; Gary P Zaloga; Rafat A Siddiqui
Journal:  Lipids Health Dis       Date:  2015-02-18       Impact factor: 3.876

4.  Immunomodulation by lipid emulsions in pulmonary inflammation: a randomized controlled trial.

Authors:  Matthias Hecker; Tomke Linder; Juliane Ott; Hans-Dieter Walmrath; Jürgen Lohmeyer; István Vadász; Leigh M Marsh; Susanne Herold; Martin Reichert; Anja Buchbinder; Rory Edward Morty; Britta Bausch; Tobias Fischer; Richard Schulz; Friedrich Grimminger; Martin Witzenrath; Matt Barnes; Werner Seeger; Konstantin Mayer
Journal:  Crit Care       Date:  2015-05-12       Impact factor: 9.097

5.  Immunomodulation by fish-oil containing lipid emulsions in murine acute respiratory distress syndrome.

Authors:  Matthias Hecker; Juliane Ott; Christoph Sondermann; Martina Schaefer; Martin Obert; Andreas Hecker; Rory E Morty; Istvan Vadasz; Susanne Herold; Bernhard Rosengarten; Martin Witzenrath; Werner Seeger; Konstantin Mayer
Journal:  Crit Care       Date:  2014-04-29       Impact factor: 9.097

Review 6.  Phospholipids of Animal and Marine Origin: Structure, Function, and Anti-Inflammatory Properties.

Authors:  Ronan Lordan; Alexandros Tsoupras; Ioannis Zabetakis
Journal:  Molecules       Date:  2017-11-14       Impact factor: 4.411

7.  Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury.

Authors:  Shijia Zhang; Svitlana D Danchuk; Kathleen Mp Imhof; Julie A Semon; Brittni A Scruggs; Ryan W Bonvillain; Amy L Strong; Jeffrey M Gimble; Aline M Betancourt; Deborah E Sullivan; Bruce A Bunnell
Journal:  Stem Cell Res Ther       Date:  2013-01-29       Impact factor: 6.832

8.  Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair.

Authors:  Susanne Herold; Konstantin Mayer; Juergen Lohmeyer
Journal:  Front Immunol       Date:  2011-11-24       Impact factor: 7.561

9.  Fish Oil-Based Fat Emulsion Reduces Acute Kidney Injury and Inflammatory Response in Antibiotic-Treated Polymicrobial Septic Mice.

Authors:  Juey-Ming Shih; Yao-Ming Shih; Man-Hui Pai; Yu-Chen Hou; Chiu-Li Yeh; Sung-Ling Yeh
Journal:  Nutrients       Date:  2016-03-15       Impact factor: 5.717

10.  Pretreatment with Fish Oil-Based Lipid Emulsion Modulates Muscle Leukocyte Chemotaxis in Murine Model of Sublethal Lower Limb Ischemia.

Authors:  Yao-Ming Shih; Juey-Ming Shih; Yu-Chen Hou; Chiu-Li Yeh; Cheng-Che Li; Sung-Ling Yeh
Journal:  Mediators Inflamm       Date:  2017-01-15       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.